Corrigan Mark
SEC-identified person · CIK 1250661 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Wave Life Sciences Ltd. WVE | Director | filed 2019 - 2025 |
| Trevena INC TRVN | Director | filed 2023 - 2024 |
| Nabriva Therapeutics plc NBRV | Director | filed 2016 - 2022 |
| QLT INC/BC QLTI | Director | filed 2017 - 2018 |
| Nabriva Therapeutics Plc NBRV | Director | filed 2017 - 2017 |
| Colucid Pharmaceuticals, Inc. CLCD | Director | filed 2015 - 2017 |
| Zalicus Inc. ZLCS | Director · President & CEO | filed 2009 - 2015 |
| Cubist Pharmaceuticals INC cbst | Director | filed 2008 - 2015 |
| Avanir Pharmaceuticals, INC. AVNR | Director | filed 2014 - 2014 |
| Sepracor INC /DE/ SEPR | Executive, VP R&D | filed 2006 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.